| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | ||
|---|---|---|---|---|---|---|
| Total Revenue | ||||||
| Cost of Revenue | ||||||
| Gross Profit | ||||||
| Gross Profit Margin (%) | ||||||
| R&D Expense | ||||||
| SG&A Expense | ||||||
| Total Operating Expenses | ||||||
| Operating Income or Loss | ||||||
| Operating Margin (%) | ||||||
| Interest Expense | ||||||
| Total Other Income/Expenses | ||||||
| Income Before Tax | ||||||
| Income Tax Expense | ||||||
| Income from Continuing Ops. | ||||||
| Net Income | ||||||
| Net Profit Margin (%) | ||||||
| Net Income Available to Common Shareholders | ||||||
| Basic EPS | ||||||
| Diluted EPS | ||||||
| Basic Average Shares | ||||||
| Diluted Average Shares |
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit Margin (%) | |||||||||||||||||||
| R&D Expense | |||||||||||||||||||
| SG&A Expense | |||||||||||||||||||
| Total Operating Expenses | |||||||||||||||||||
| Operating Income or Loss | |||||||||||||||||||
| Operating Margin (%) | |||||||||||||||||||
| Interest Expense | |||||||||||||||||||
| Total Other Income/Expenses | |||||||||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income from Continuing Ops. | |||||||||||||||||||
| Net Income | |||||||||||||||||||
| Net Profit Margin (%) | |||||||||||||||||||
| Net Income Available to Common Shareholders | |||||||||||||||||||
| Basic EPS | |||||||||||||||||||
| Diluted EPS | |||||||||||||||||||
| Basic Average Shares | |||||||||||||||||||
| Diluted Average Shares |
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | ||
|---|---|---|---|---|---|---|
| Current Assets | ||||||
| Cash & Cash Equivalents | ||||||
| Marketable Securities | ||||||
| Receivables | ||||||
| Inventories | ||||||
| Other Current Assets | ||||||
| Total Current Assets | ||||||
| Non-Current Assets | ||||||
| Marketable Securities | ||||||
| PPE Net | ||||||
| Intangibles inc. Goodwill | ||||||
| Other Non-Current Assets | ||||||
| Total Non-Current Assets | ||||||
| Total Assets | ||||||
| Current Liabilities | ||||||
| Accounts Payable | ||||||
| Deferred Revenues | ||||||
| Debt, Current | ||||||
| Accrued Liabilities | ||||||
| Other Current Liabilities | ||||||
| Total Current Liabilities | ||||||
| Non-Current Liabilities | ||||||
| Deferred Revenues | ||||||
| Debt, Non-Current | ||||||
| Other Non-Current Liabilities | ||||||
| Total Non-Current Liabilities | ||||||
| Total Liabilities | ||||||
| Shareholders' Equity | ||||||
| Common Stock | ||||||
| Additional Paid-In Capital | ||||||
| Retained Earnings | ||||||
| Other Shareholders' Equity | ||||||
| Total Shareholders' Equity | ||||||
| Total Liabilities & Shareholders' Equity |
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||||||||||||
| Cash & Cash Equivalents | |||||||||||||||||||
| Marketable Securities | |||||||||||||||||||
| Receivables | |||||||||||||||||||
| Inventories | |||||||||||||||||||
| Other Current Assets | |||||||||||||||||||
| Total Current Assets | |||||||||||||||||||
| Non-Current Assets | |||||||||||||||||||
| Marketable Securities | |||||||||||||||||||
| PPE Net | |||||||||||||||||||
| Intangibles inc. Goodwill | |||||||||||||||||||
| Other Non-Current Assets | |||||||||||||||||||
| Total Non-Current Assets | |||||||||||||||||||
| Total Assets | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Accounts Payable | |||||||||||||||||||
| Deferred Revenues | |||||||||||||||||||
| Debt, Current | |||||||||||||||||||
| Accrued Liabilities | |||||||||||||||||||
| Other Current Liabilities | |||||||||||||||||||
| Total Current Liabilities | |||||||||||||||||||
| Non-Current Liabilities | |||||||||||||||||||
| Deferred Revenues | |||||||||||||||||||
| Debt, Non-Current | |||||||||||||||||||
| Other Non-Current Liabilities | |||||||||||||||||||
| Total Non-Current Liabilities | |||||||||||||||||||
| Total Liabilities | |||||||||||||||||||
| Shareholders' Equity | |||||||||||||||||||
| Common Stock | |||||||||||||||||||
| Additional Paid-In Capital | |||||||||||||||||||
| Retained Earnings | |||||||||||||||||||
| Other Shareholders' Equity | |||||||||||||||||||
| Total Shareholders' Equity | |||||||||||||||||||
| Total Liabilities & Shareholders' Equity |
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | ||
|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||||
| Net Income | ||||||
| Depreciation & Amortization | ||||||
| Deferred Income Taxes | ||||||
| Stock Based Compensation | ||||||
| Accounts Receivable | ||||||
| Inventory | ||||||
| Accounts Payable | ||||||
| Deferred Revenue | ||||||
| Other Non-Cash | ||||||
| Operating Cash Flow | ||||||
| Cash Flows from Investing Activities | ||||||
| PPE Investments | ||||||
| Net Acquisitions | ||||||
| Purchase of Investments | ||||||
| Sale of Investments | ||||||
| Other Investing Activity | ||||||
| Investing Cash Flow | ||||||
| Cash Flows from Financing Activities | ||||||
| Debt Issued | ||||||
| Proceeds from Debt Repayment | ||||||
| Debt Repayment | ||||||
| Proceeds from Sale of Equity | ||||||
| Equity Repurchased | ||||||
| Dividend Paid | ||||||
| Other Financing Activity | ||||||
| Financing Cash Flow | ||||||
| Cash Position | ||||||
| Beginning Cash Position | ||||||
| End Cash Position | ||||||
| Change in Cash | ||||||
| Free Cash Flow | ||||||
| Operating Cash Flow | ||||||
| Capital Expenditure | ||||||
| Free Cash Flow |
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||||||||||||||||
| Net Income | |||||||||||||||||||
| Depreciation & Amortization | |||||||||||||||||||
| Deferred Income Taxes | |||||||||||||||||||
| Stock Based Compensation | |||||||||||||||||||
| Accounts Receivable | |||||||||||||||||||
| Inventory | |||||||||||||||||||
| Accounts Payable | |||||||||||||||||||
| Deferred Revenue | |||||||||||||||||||
| Other Non-Cash | |||||||||||||||||||
| Operating Cash Flow | |||||||||||||||||||
| Cash Flows from Investing Activities | |||||||||||||||||||
| PPE Investments | |||||||||||||||||||
| Net Acquisitions | |||||||||||||||||||
| Purchase of Investments | |||||||||||||||||||
| Sale of Investments | |||||||||||||||||||
| Other Investing Activity | |||||||||||||||||||
| Investing Cash Flow | |||||||||||||||||||
| Cash Flows from Financing Activities | |||||||||||||||||||
| Debt Issued | |||||||||||||||||||
| Proceeds from Debt Repayment | |||||||||||||||||||
| Debt Repayment | |||||||||||||||||||
| Proceeds from Sale of Equity | |||||||||||||||||||
| Equity Repurchased | |||||||||||||||||||
| Dividend Paid | |||||||||||||||||||
| Other Financing Activity | |||||||||||||||||||
| Financing Cash Flow | |||||||||||||||||||
| Cash Position | |||||||||||||||||||
| Beginning Cash Position | |||||||||||||||||||
| End Cash Position | |||||||||||||||||||
| Change in Cash | |||||||||||||||||||
| Free Cash Flow | |||||||||||||||||||
| Operating Cash Flow | |||||||||||||||||||
| Capital Expenditure | |||||||||||||||||||
| Free Cash Flow |
